Changes in the Activity of Proteasomes and Calpains in Metastases of Human Lung Cancer and Breast Cancer
- Authors: Shashova E.E.1, Kolegova E.S.1, Zav’yalov A.A.1, Slonimskaya E.M.1, Kondakova I.V.1
- 
							Affiliations: 
							- Tomsk National Research Medical Center, Russian Academy of Sciences
 
- Issue: Vol 163, No 4 (2017)
- Pages: 486-489
- Section: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/239017
- DOI: https://doi.org/10.1007/s10517-017-3834-7
- ID: 239017
Cite item
Abstract
In patients with breast cancer and lung cancer, chymotrypsin-like and caspase-like activities of proteasomes and total activity of calpains in the primary tumor nodes and lymphogenic metastasis are elevated in comparison with the corresponding normal tissues. The development of lymphogenic metastases of breast cancer and lung cancer was associated with opposite change in caspase-like activity of proteasomes. These results can be useful for the development of methods for evaluation of aggressiveness of breast and lung cancer.
About the authors
E. E. Shashova
Tomsk National Research Medical Center, Russian Academy of Sciences
														Email: kondakova@onkology.tomsk.ru
				                					                																			                												                	Russian Federation, 							Tomsk						
E. S. Kolegova
Tomsk National Research Medical Center, Russian Academy of Sciences
														Email: kondakova@onkology.tomsk.ru
				                					                																			                												                	Russian Federation, 							Tomsk						
A. A. Zav’yalov
Tomsk National Research Medical Center, Russian Academy of Sciences
														Email: kondakova@onkology.tomsk.ru
				                					                																			                												                	Russian Federation, 							Tomsk						
E. M. Slonimskaya
Tomsk National Research Medical Center, Russian Academy of Sciences
														Email: kondakova@onkology.tomsk.ru
				                					                																			                												                	Russian Federation, 							Tomsk						
I. V. Kondakova
Tomsk National Research Medical Center, Russian Academy of Sciences
							Author for correspondence.
							Email: kondakova@onkology.tomsk.ru
				                					                																			                												                	Russian Federation, 							Tomsk						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					